An algorithm which included both conjunctival and biomarker measurements (microvascular velocity, adiponectin and NT-proBNP) was identified that differentiated the post-MI from control (AUROC 0.967, sensitivity 93.0%, specificity 91.5%) (Table 4 and Fig. 2). This evidence concerns the gene ADIPOQ and myocardial infarction.